Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Cardiomyopathy"" wg kryterium: Temat

  Lista filtrów
Wyrównaj
Wyświetlanie 1-20 z 1654
Tytuł:
Effect of beta-blocker therapy on the response to mavacamten in patients with symptomatic obstructive hypertrophic cardiomyopathy.
Autorzy:
Wheeler MT; Division of Cardiovascular Medicine, Center for Inherited Cardiovascular Disease, Stanford University, Stanford, CA, USA.
Jacoby D; Section of Cardiovascular Medicine, Department of Internal Medicine, Yale University, New Haven, CT, USA.
Elliott PM; University College London & St. Bartholomew's Hospital, London, UK.
Saberi S; Division of Cardiovascular Medicine, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor, MI, USA.
Hegde SM; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Lakdawala NK; Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.
Myers J; Division of Cardiology, Veterans Affairs Palo Alto Healthcare System, Palo Alto, CA, USA.; Stanford University, Palo Alto, CA, USA.
Sehnert AJ; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Edelberg JM; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Li W; MyoKardia, Inc., a wholly owned subsidiary of Bristol Myers Squibb, Brisbane, CA, USA.
Olivotto I; Cardiomyopathy Unity, Azienda Ospedaliera Universitaria Careggi and University of Florence, Florence, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 260-270. Date of Electronic Publication: 2023 Feb 01.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Hypertrophic*/diagnosis
Heart Failure*/drug therapy
Humans ; Adrenergic beta-Antagonists/therapeutic use ; Benzylamines/adverse effects ; Heart
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Mavacamten in obstructive hypertrophic cardiomyopathy - Are beta-blockers blocking part of its shine?
Autorzy:
Dominguez F; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain.; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.
Cabrera E; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2023 Feb; Vol. 25 (2), pp. 271-273. Date of Electronic Publication: 2023 Jan 11.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Heart Failure*
Cardiomyopathy, Hypertrophic*
Humans ; Adrenergic beta-Antagonists ; Benzylamines
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC).
Autorzy:
de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Heymans S; Department of Cardiology, Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.; Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Backs J; Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.; German Center for Cardiovascular Research (DZHK), Partner Site Heidelberg/Mannheim, Heidelberg, Germany.
Carrier L; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Coats AJS; Faculty of Medicine, University of Warwick, Warwick, UK.
Dimmeler S; Institute for Cardiovascular Regeneration, Goethe University, Frankfurt, Germany.; German Center for Cardiovascular Research (DZHK), Frankfurt, Germany.; Cardio-Pulmonary Institute (CPI), Frankfurt, Germany.
Eschenhagen T; Department of Experimental Pharmacology and Toxicology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.; German Centre for Cardiovascular Research (DZHK), partner site Hamburg/Kiel/Lübeck, Hamburg, Germany.
Filippatos G; Department of Cardiology, National and Kapodistrian University of Athens, School of Medicine, Attikon University Hospital, Athens, Greece.
Gepstein L; Department of Cardiology, Rambam Health Care Campus, Technion - Israel Institute of Technology, Haifa, Israel.
Hulot JS; Université de Paris, INSERM, PARCC, Paris, France.; CIC1418 and DMU CARTE, AP-HP, Hôpital Européen Georges-Pompidou, Paris, France.
Knöll R; Department of Medicine, Integrated Cardio Metabolic Centre (ICMC), Heart and Vascular Theme, Karolinska Institute, Stockholm, Sweden.; Bioscience, Cardiovascular, Renal & Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Kupatt C; Department of Cardiology, University Clinic rechts der Isar, Technical University of Munich, Germany and German Center for Cardiovascular Research (DZHK), Munich Heart Alliance, Munich, Germany.
Linke WA; Institute of Physiology II, University Hospital Muenster, Muenster, Germany.
Seidman CE; Department of Genetics, Harvard Medical School, Boston, MA, USA.; Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.; Howard Hughes Medical Institute, Harvard University, Boston, MA, USA.
Tocchetti CG; Department of Translational Medical Sciences, Center for Basic and Clinical Immunology Research (CISI); Interdepartmental Center for Clinical and Translational Research (CIRCET); Interdepartmental Hypertension Research Center (CIRIAPA), Federico II University, Naples, Italy.
van der Velden J; Department of Physiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Walsh R; Department of Clinical and Experimental Cardiology, Amsterdam UMC, Amsterdam Cardiovascular Sciences, University of Amsterdam, Heart Center, Amsterdam, The Netherlands.
Seferovic PM; Serbian Academy of Sciences and Arts, Belgrade, Serbia.; Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.; Fraunhofer Institute for Toxicology and Experimental Medicine, Hannover, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Mar; Vol. 24 (3), pp. 406-420. Date of Electronic Publication: 2022 Jan 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiology*
Cardiomyopathies*/genetics
Cardiomyopathy, Dilated*/genetics
Cardiomyopathy, Dilated*/therapy
Cardiomyopathy, Hypertrophic*/genetics
Cardiomyopathy, Hypertrophic*/therapy
Heart Failure*/genetics
Heart Failure*/therapy
Humans ; Myocardium/pathology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Transient versus persistent improved ejection fraction in non-ischaemic dilated cardiomyopathy.
Autorzy:
Manca P; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
Stolfo D; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Merlo M; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
Gregorio C; Biostatistics Unit, Department of Medical Sciences, University of Trieste, Trieste, Italy.; MOX - Department of Mathematics, Politecnico di Milano, Milan, Italy.
Cannatà A; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.; Department of Cardiovascular Science, Faculty of Life Science and Medicine, King's College London, London, UK.
Ramani F; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
Nuzzi V; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
Lund LH; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Savarese G; Division of Cardiology, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Sinagra G; Cardiothoracovascular Department, Azienda Sanitaria Universitaria Giuliano Isontina, University of Trieste, Trieste, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1171-1179. Date of Electronic Publication: 2022 May 09.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiomyopathy, Dilated*
Heart Failure*
Heart-Assist Devices*
Humans ; Prognosis ; Stroke Volume/physiology ; Ventricular Function, Left/physiology
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Combination of late gadolinium enhancement and genotype improves prediction of prognosis in non-ischaemic dilated cardiomyopathy.
Autorzy:
Mirelis JG; Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).
Escobar-Lopez L; Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).
Ochoa JP; Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).
Espinosa MÁ; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Villacorta E; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiac Diseases Unit. Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), Salamanca, Spain.; Departament of Medicine, Facultad de Medicina, Universidad de Salamanca, Salamanca, Spain.
Navarro M; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).; Inherited Cardiac Disease Unit, University Hospital Virgen de la Arrixaca, Murcia, Spain.
Casas G; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiovascular Diseases Unit. Department of Cardiology. Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Mora-Ayestarán N; Department of Cardiology, Área del Corazón, Complejo Hospitalario de Navarra, Pamplona, Spain.
Barriales-Villa R; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiac Diseases Unit. Instituto de Investigación Biomédica de A Coruña (INIBIC), Complexo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde (SERGAS), Universidade da Coruña, A Coruña, Spain.
Mogollón-Jiménez MV; Department of Cardiology, Complejo Hospitalario Universitario de Cáceres, Cáceres, Spain.
García-Pinilla JM; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Heart Failure and Familial Heart Diseases Unit, Cardiology Department, Hospital Universitario Virgen de la Victoria, IBIMA, Malaga, Spain.
García-Granja PE; Department of Cardiology, Instituto de Ciencias del Corazón (ICICOR), Hospital Clínico Universitario Valladolid, Valladolid, Spain.
Climent V; Inherited Cardiovascular Diseases Unit, Department of Cardiology, Hospital General Universitario de Alicante, Institute of Health and Biomedical Research, Alicante, Spain.
Palomino-Doza J; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiac Diseases Unit, Cardiology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain.
García-Álvarez A; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Cardiology Departament, Hospital Clínic, IDIBAPS, Universitat de Barcelona, Barcelona, Spain.; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Álvarez-Barredo M; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Xenética Cardiovascular, Instituto de investigación Sanitaria de Santiago, Unidad de Cardiopatías Familiares, Department of Cardiology, Complexo Hospitalario Universitario de Santiago de Compostela, Santiago de Compostela, Spain.
Cabrera-Borrego E; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Department of Cardiology, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Ripoll-Vera T; Inherited Cardiac Diseases Unit, Cardiology Department, Hospital Universitario Son Llatzer & IdISBa, Palma de Mallorca, Spain.
Peña-Peña ML; Inherited Cardiac Diseases Unit, Hospital Universitario Virgen del Rocío, Seville, Spain.
Rodríguez-González E; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Gallego-Delgado M; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiac Diseases Unit. Department of Cardiology, Instituto de Investigación Biomédica de Salamanca (IBSAL), Complejo Asistencial Universitario de Salamanca, Gerencia Regional de Salud de Castilla y León (SACYL), Salamanca, Spain.
Gonzalez-Carrillo J; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).; Inherited Cardiac Disease Unit, University Hospital Virgen de la Arrixaca, Murcia, Spain.
Fernández-Ávila A; Department of Cardiology, Hospital General Universitario Gregorio Marañón, Madrid, Spain.
Rodríguez-Palomares JF; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Inherited Cardiovascular Diseases Unit. Department of Cardiology. Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Brugada R; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Department of Cardiology, Hospital Univesitari Dr. Josep Trueta, Girona, Spain.
Bayes-Genis A; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; Heart Institute. Hospital Universitari Germans Trias i Pujol. Badalona, Barcelona, Spain.
Dominguez F; Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).
García-Pavía P; Department of Cardiology, Hospital Universitario Puerta de Hierro, IDIPHISA, Madrid, Spain.; CIBER Cardiovascular, Instituto de Salud Carlos III, Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART).; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.; Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcón, Spain.; Universidad Autónoma de Madrid, Madrid, Spain.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1183-1196. Date of Electronic Publication: 2022 May 22.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*
Heart Failure*/diagnosis
Heart Failure*/genetics
Arrhythmias, Cardiac ; Cicatrix ; Contrast Media ; Female ; Gadolinium ; Genotype ; Humans ; Magnetic Resonance Imaging, Cine ; Male ; Predictive Value of Tests ; Prognosis ; Retrospective Studies
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiology of Takotsubo syndrome: still a puzzle. Letter regarding the article 'Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications'.
Autorzy:
Madias JE; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Division of Cardiology, Elmhurst Hospital Center, Elmhurst, NY, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1323. Date of Electronic Publication: 2021 Dec 06.
Typ publikacji:
Letter; Comment
MeSH Terms:
Cardiology*
Heart Failure*
Takotsubo Cardiomyopathy*
Gonadal Steroid Hormones ; Humans ; Myocardium
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Dilated cardiomyopathy - details make the difference.
Autorzy:
McGurk KA; National Heart and Lung Institute, Imperial College London, London, UK.
Halliday BP; National Heart and Lung Institute, Imperial College London, London, UK.; Cardiovascular Research Centre at Royal Brompton and Harefield Hospitals, part of Guy's and St Thomas' NHS Foundation Trust, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jul; Vol. 24 (7), pp. 1197-1199. Date of Electronic Publication: 2022 Jul 05.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Cardiomyopathy, Dilated*/diagnosis
Heart Failure*/therapy
Humans ; Stroke Volume
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiology and therapy of Takotsubo syndrome. Letter regarding the article 'Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system'.
Autorzy:
Madias JE; Icahn School of Medicine at Mount Sinai, New York, NY, USA.; Division of Cardiology, Elmhurst Hospital Center, Elmhurst, NY, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Jun; Vol. 24 (6), pp. 1143. Date of Electronic Publication: 2022 Jan 05.
Typ publikacji:
Letter; Comment
MeSH Terms:
Cardiology*
Heart Failure*
Takotsubo Cardiomyopathy*
Catecholamines ; Humans ; Sympathetic Nervous System
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 1: overview and the central role for catecholamines and sympathetic nervous system.
Autorzy:
Omerovic E; Department of Cardiology, Sahlgrenska University Hospital and Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Citro R; Heart Department, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy.
Bossone E; Division of Cardiology, A. Cardarelli Hospital, Naples, Italy.
Redfors B; Department of Cardiology, Sahlgrenska University Hospital and Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Backs J; Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg/Mannheim, Germany.
Bruns B; Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.; DZHK (German Centre for Cardiovascular Research), Partner Site, Heidelberg/Mannheim, Germany.; Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany.
Ciccarelli M; Department of Medicine, Surgery, and Dentistry, University of Salerno, Salerno, Italy.
Couch LS; National Heart and Lung Institute, Imperial College, London, UK.
Dawson D; Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, UK.
Grassi G; Clinica Medica, University of Milano Bicocca, Milan, Italy.
Iacoviello M; University Cardiology Unit, Cardiothoracic Department, University Hospital, Bari, Italy.
Parodi G; Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.
Schneider B; Sana Kliniken, Lübeck, Germany.
Templin C; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Ghadri JR; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania and University of Medicine Carol Davila, Bucharest, Romania.
Tocchetti CG; Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy.
van der Velden J; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Heymans S; Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology and Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Lyon AR; National Heart and Lung Institute, Imperial College, London, UK.; Department of Cardiology, Royal Brompton Hospital, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Feb; Vol. 24 (2), pp. 257-273. Date of Electronic Publication: 2022 Feb 16.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiology*
Heart Failure*
Takotsubo Cardiomyopathy*
Catecholamines ; Humans ; Sympathetic Nervous System
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Pathophysiology of Takotsubo syndrome - a joint scientific statement from the Heart Failure Association Takotsubo Syndrome Study Group and Myocardial Function Working Group of the European Society of Cardiology - Part 2: vascular pathophysiology, gender and sex hormones, genetics, chronic cardiovascular problems and clinical implications.
Autorzy:
Omerovic E; Department of Cardiology, Sahlgrenska University Hospital and Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Citro R; Heart Department, University Hospital 'San Giovanni di Dio e Ruggi d'Aragona', Salerno, Italy.
Bossone E; Division of Cardiology, A. Cardarelli Hospital, Naples, Italy.
Redfors B; Department of Cardiology, Sahlgrenska University Hospital and Department of Molecular and Clinical Medicine/Wallenberg Laboratory, Institute of Medicine, Sahlgrenska Academy, Gothenburg University, Gothenburg, Sweden.
Backs J; Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.; DZHK (German Centre for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Heidelberg, Germany.
Bruns B; Institute of Experimental Cardiology, Heidelberg University, Heidelberg, Germany.; DZHK (German Centre for Cardiovascular Research) Partner Site Heidelberg/Mannheim, Heidelberg, Germany.; Department of General Internal Medicine and Psychosomatics, University of Heidelberg, Heidelberg, Germany.
Ciccarelli M; Department of Medicine, Surgery, and Dentistry, University of Salerno, Salerno, Italy.
Couch LS; National Heart and Lung Institute, Imperial College, London, UK.
Dawson D; Aberdeen Cardiovascular and Diabetes Centre, School of Medicine and Dentistry, University of Aberdeen, Aberdeen, Scotland, UK.
Grassi G; Clinica Medica, University of Milano Bicocca, Milan, Italy.
Iacoviello M; University Cardiology Unit, Cardiothoracic Department, University Hospital, Bari, Italy.
Parodi G; Clinical and Interventional Cardiology, Sassari University Hospital, Sassari, Italy.
Schneider B; Sana Kliniken, Lübeck, Germany.
Templin C; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Ghadri JR; University Heart Center, Department of Cardiology, University Hospital Zurich, Zurich, Switzerland.
Thum T; Institute of Molecular and Translational Therapeutic Strategies, Hannover Medical School, Hannover, Germany.
Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. C.C. Iliescu', Bucharest, Romania and University of Medicine Carol Davila, Bucharest, Romania.
Tocchetti CG; Department of Translational Medical Sciences and Interdepartmental Center for Clinical and Translational Research (CIRCET), Federico II University, Naples, Italy.
van der Velden J; Department of Physiology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Heymans S; Department of Cardiology, CARIM School for Cardiovascular Diseases, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Cardiovascular Sciences, Centre for Molecular and Vascular Biology and Department of Cardiovascular Sciences, University of Leuven, Leuven, Belgium.
Lyon AR; National Heart and Lung Institute, Imperial College, London, UK.; Department of Cardiology, Royal Brompton Hospital, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2022 Feb; Vol. 24 (2), pp. 274-286. Date of Electronic Publication: 2021 Nov 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiology*
Heart Failure*/genetics
MicroRNAs*
Takotsubo Cardiomyopathy*/genetics
Gonadal Steroid Hormones ; Humans
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Prevalence and clinical outcomes of dystrophin-associated dilated cardiomyopathy without severe skeletal myopathy.
Autorzy:
Restrepo-Cordoba MA; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.
Wahbi K; APHP, Cochin Hospital, Cardiology Department, FILNEMUS, Paris-Descartes, Sorbonne Paris Cité University, Paris, France.
Florian AR; Division of Cardiovascular Imaging, Department of Cardiology I, University Hospital Muenster, Muenster, Germany.
Jiménez-Jáimez J; Cardiology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Politano L; Cardiomyology and Medical Genetics, University of Campania Luigi Vanvitelli, Naples, Italy.
Arad M; Leviev Heart Center, Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Climent-Paya V; Cardiology Department, University General Hospital of Alicante, Alicante, Spain. Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
Garcia-Alvarez A; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Hansen RB; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Larrañaga-Moreira JM; Inherited Cardiovascular Diseases Unit, Cardiology Service, Complexo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde (SERGAS), Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidade da Coruña, A Coruña, Spain.
Kubanek M; Department of Cardiology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Lopes LR; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Ros A; Cardiogenetics Unit, Clinical Genetics Department, University Hospital Germans Trias i Pujol, Badalona, Spain.
Jurcut R; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.; Expert Center for Rare Cardiovascular Genetic Diseases, 3rd Cardiology Department, Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C.C. Iliescu', Bucharest, Romania.
Rasmussen TB; Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark.
Ruiz-Guerrero L; Department of Cardiology, Hospital Universitario Marqués de Valdecilla, IDIVAL, Santander, Spain.
Pribe-Wolferts R; Institute for Cardiomyopathies Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.
Palomino-Doza J; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Inherited cardiac diseases unit, Cardiology Department, Hospital Universitario 12 de Octubre, Instituto de Investigación i+12, Madrid, Spain.
Bilinska Z; Unit for Screening Studies in Inherited Cardiovascular Diseases, National Institute of Cardiology, Warsaw, Poland.
Rodríguez-Palomares JF; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Hospital Universitari Vall d'Hebron, Department of Cardiology, Vall d'Hebron Institut de Recerca (VHIR), Universitat Autònoma de Barcelona, Barcelona, Spain.
Van Loon RLE; Department of Genetics, University Medical Center Utrecht, University of Utrecht, Utrecht, The Netherlands.
Basurte Elorz MT; Heart Area, Complejo Hospitalario de Navarra, Pamplona, Spain.
Quarta G; Cardiology Department, ASST Papa Giovanni XXIII, Bergamo, Italy.
Robledo Iñarritu M; Hospital Universitario Araba - Txagorritxu, Vitoria, Spain.
Verdonschot JAJ; Department of Cardiology and Department of Clinical Genetics, Maastricht University Medical Center, Maastricht, The Netherlands.
Stojkovic T; Referral Center of Neuromuscular Diseases, Myology Institute, Pitié-Salpêtrière Hospital, Paris, France.
Shomanova Z; Division of Cardiovascular Imaging, Department of Cardiology I, University Hospital Muenster, Muenster, Germany.
Bermudez-Jimenez F; Cardiology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
Palladino A; Cardiomyology and Medical Genetics, University of Campania Luigi Vanvitelli, Naples, Italy.
Freimark D; Leviev Heart Center, Sheba Medical Center and The Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
García-Álvarez MI; Cardiology Department, University General Hospital of Alicante, Alicante, Spain. Institute of Health and Biomedical Research (ISABIAL), Alicante, Spain.
Jorda P; Institut Clinic Cardiovascular, IDIBAPS, Hospital Clínic, University of Barcelona, Barcelona, Spain.
Dominguez F; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.
Ochoa JP; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Madrid, Spain.; Cardiology Department, Health in Code, A Coruña, Spain.
Girolami F; Department of Paediatric Cardiology, Meyer Children's Hospital, Florence, Italy.
Brugada R; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitari Dr Josep Trueta, Girona, Spain.; Medical Science Department, School of Medicine, University of Girona, Girona, Spain.
Meder B; Institute for Cardiomyopathies Heidelberg, University Hospital Heidelberg, Heidelberg, Germany.; Stanford University School of Medicine, Department of Genetics, Stanford, CA, USA.
Barriales-Villa R; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; Inherited Cardiovascular Diseases Unit, Cardiology Service, Complexo Hospitalario Universitario de A Coruña, Servizo Galego de Saúde (SERGAS), Instituto de Investigación Biomédica de A Coruña (INIBIC), Universidade da Coruña, A Coruña, Spain.
Mogensen J; Department of Cardiology, Odense University Hospital, Odense, Denmark.
Laforêt P; APHP, Hôpital Raymond Poincaré, Centre de Référence des Maladies Neuromusculaires Nord-Est-Île de France, Garches, France.
Yilmaz A; Division of Cardiovascular Imaging, Department of Cardiology I, University Hospital Muenster, Muenster, Germany.
Elliott P; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.; Barts Heart Centre, St Bartholomew's Hospital, Barts Health NHS Trust, London, UK.; Centre for Heart Muscle Disease, Institute of Cardiovascular Science, University College London, London, UK.
Garcia-Pavia P; Heart Failure and Inherited Cardiac Diseases Unit, Department of Cardiology, Hospital Universitario Puerta de Hierro, Madrid, Spain.; Centro de Investigación Biomédica en Red en Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain.; European Reference Network for Rare and Low Prevalence Complex Diseases of the Heart (ERN-GUARDHEART), Amsterdam, The Netherlands.; Universidad Francisco de Vitoria (UFV), Pozuelo de Alarcon, Spain.; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain.
Pokaż więcej
Corporate Authors:
European Genetic Cardiomyopathies Initiative Investigators (see online supplementary Appendix S1)
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Aug; Vol. 23 (8), pp. 1276-1286. Date of Electronic Publication: 2021 Jun 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*/epidemiology
Cardiomyopathy, Dilated*/genetics
Heart Failure*/epidemiology
Muscular Diseases*
Adolescent ; Adult ; Dystrophin/genetics ; Female ; Humans ; Male ; Middle Aged ; Prevalence ; Retrospective Studies ; Stroke Volume ; Ventricular Function, Left ; Young Adult
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
The combination of carboxy-terminal propeptide of procollagen type I blood levels and late gadolinium enhancement at cardiac magnetic resonance provides additional prognostic information in idiopathic dilated cardiomyopathy - A multilevel assessment of myocardial fibrosis in dilated cardiomyopathy.
Autorzy:
Raafs AG; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Verdonschot JAJ; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Henkens MTHM; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Adriaans BP; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, The Netherlands.
Wang P; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Derks K; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.
Abdul Hamid MA; Department of Pathology, Maastricht University Medical Centre, Maastricht, The Netherlands.
Knackstedt C; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
van Empel VPM; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Díez J; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain.; Departments of Nephrology and of Cardiology and Cardiac Surgery, University of Navarra Clinic, Pamplona, Spain.
Brunner-La Rocca HP; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Brunner HG; Department of Clinical Genetics, Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Human Genetics, and Donders Centre for Neuroscience, Radboud UMC, Nijmegen, The Netherlands.
González A; Program of Cardiovascular Diseases, CIMA Universidad de Navarra and IdiSNA, Pamplona, Spain.; CIBERCV, Carlos III Institute of Health, Madrid, Spain.
Bekkers SCAM; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Heymans SRB; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.; Department of Cardiovascular Research, University of Leuven, Leuven, Belgium.; Netherlands Heart Institute (Nl-HI), Utrecht, The Netherlands.
Hazebroek MR; Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Centre, Maastricht, The Netherlands.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Jun; Vol. 23 (6), pp. 933-944. Date of Electronic Publication: 2021 Jun 24.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*/diagnosis
Cardiomyopathy, Dilated*/pathology
Heart Failure*/pathology
Collagen Type I ; Contrast Media ; Fibrosis ; Gadolinium ; Humans ; Magnetic Resonance Imaging, Cine ; Magnetic Resonance Spectroscopy ; Models, Statistical ; Myocardium/pathology ; Predictive Value of Tests ; Prognosis
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Myocardial remodelling after withdrawing therapy for heart failure in patients with recovered dilated cardiomyopathy: insights from TRED-HF.
Autorzy:
Halliday BP; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Owen R; London School of Hygiene and Tropical Medicine, London, UK.
Gregson J; London School of Hygiene and Tropical Medicine, London, UK.
S Vassiliou V; Faculty of Medicine and Health Sciences, Norwich Medical School, University of East Anglia, Norwich, UK.
Chen X; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Wage R; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Lota AS; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Khalique Z; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Tayal U; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Hammersley DJ; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Jones RE; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Baksi AJ; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Cowie MR; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Cleland JGF; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.; Robertson Centre for Biostatistics, University of Glasgow, Glasgow, UK.
Pennell DJ; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Prasad SK; Cardiovascular Research Centre, Royal Brompton Hospital & National Heart Lung Institute, Imperial College, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Feb; Vol. 23 (2), pp. 293-301. Date of Electronic Publication: 2020 Dec 14.
Typ publikacji:
Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*
Heart Failure*
Humans ; Stroke Volume ; Ventricular Function, Left ; Ventricular Remodeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
Heart failure in cardiomyopathies: a position paper from the Heart Failure Association of the European Society of Cardiology.
Autorzy:
Seferović PM; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Polovina M; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Bauersachs J; Department of Cardiology and Angiology, Medical School Hannover, Hannover, Germany.
Arad M; Cardiomyopathy Clinic and Heart Failure Institute, Leviev Heart Center, Sheba Medical Center and Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.
Ben Gal T; Department of Cardiology, Rabin Medical Center, Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
Lund LH; Department of Medicine, Karolinska Institutet, and Heart and Vascular Theme, Karolinska University Hospital, Stockholm, Sweden.
Felix SB; Department of Internal Medicine B, University Medicine Greifswald, Greifswald, Germany.
Arbustini E; Centre for Inherited Cardiovascular Diseases, IRCCS Foundation, University Hospital Policlinico San Matteo, Pavia, Italy.
Caforio ALP; Division of Cardiology, Department of Cardiological, Thoracic and Vascular Sciences, University of Padua, Padua, Italy.
Farmakis D; University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
Filippatos GS; University of Cyprus Medical School, Nicosia, Cyprus; Heart Failure Unit, Department of Cardiology, Athens University Hospital Attikon, National and Kapodistrian University of Athens, Athens, Greece.
Gialafos E; Second Department of Cardiology, Heart Failure and Preventive Cardiology Section, Henry Dunant Hospital, Athens, Greece.
Kanjuh V; Serbian Academy of Sciences and Arts, Belgrade, Serbia.
Krljanac G; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Limongelli G; Department of Cardiothoracic Sciences, Università della Campania 'Luigi VanvitellI', Monaldi Hospital, AORN Colli, Centro di Ricerca Cardiovascolare, Ospedale Monaldi, AORN Colli, Naples, Italy, and UCL Institute of Cardiovascular Science, London, UK.
Linhart A; Second Department of Medicine, Department of Cardiovascular Medicine, General University Hospital, Charles University in Prague, Prague, Czech Republic.
Lyon AR; National Heart and Lung Institute, Imperial College London and Royal Brompton Hospital, London, UK.
Maksimović R; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Centre for Radiology and Magnetic Resonance Imaging, Clinical Centre of Serbia, Belgrade, Serbia.
Miličić D; Department of Cardiovascular Diseases, University Hospital Center Zagreb, University of Zagreb, Zagreb, Croatia.
Milinković I; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Noutsias M; Mid-German Heart Center, Department of Internal Medicine III, Division of Cardiology, Angiology and Intensive Medical Care, University Hospital Halle, Martin-Luther-University Halle, Halle, Germany.
Oto A; Department of Cardiology, Hacettepe University Faculty of Medicine, Ankara, Turkey.
Oto Ö; Department of Cardiovascular Surgery, Dokuz Eylül University Faculty of Medicine, İzmir, Turkey.
Pavlović SU; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Pacemaker Center, Clinical Center of Serbia, Belgrade, Serbia.
Piepoli MF; Heart Failure Unit, Cardiology, G. da Saliceto Hospital, Piacenza, Italy.
Ristić AD; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Rosano GMC; Department of Medical Sciences, IRCCS San Raffaele, Rome, Italy, and Cardiology Clinical Academic Group, St George's Hospitals NHS Trust University of London, London, UK.
Seggewiss H; Medizinische Klinik, Kardiologie & Internistische Intensivmedizin, Klinikum Würzburg-Mitte, Würzburg, Germany.
Ašanin M; University of Belgrade Faculty of Medicine, Belgrade, Serbia.; Department of Cardiology, Clinical Center of Serbia, Belgrade, Serbia.
Seferović JP; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Clinic for Endocrinology, Diabetes and Metabolic Disorders, Clinical Center Serbia and Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Ruschitzka F; Department of Cardiology, University Heart Center, Zürich, Switzerland.
Čelutkiene J; Clinic of Cardiac and Vascular Diseases, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, Vilnius, Lithuania.; State Research Institute Centre for Innovative Medicine, Vilnius, Lithuania.
Jaarsma T; Department of Social and Welfare Studies, Faculty of Health Science, Linköping University, Linköping, Sweden.
Mueller C; Cardiovascular Research Institute Basel (CRIB) and Department of Cardiology, University Hospital Basel, University of Basel, Basel, Switzerland.
Moura B; Cardiology Department, Centro Hospitalar São João, Porto, Portugal.
Hill L; School of Nursing and Midwifery, Queen's University Belfast, Belfast, UK.
Volterrani M; Department of Cardiology, IRCCS San Raffaele Pisana, Rome, Italy.
Lopatin Y; Volgograd State Medical University, Regional Cardiology Centre Volgograd, Volgograd, Russia.
Metra M; Cardiology, Department of Medical and Surgical Specialties, Radiological Sciences, and Public Health, University of Brescia, Brescia, Italy.
Backs J; Department of Molecular Cardiology and Epigenetics, University of Heidelberg, Heidelberg, Germany.; DZHK (German Centre for Cardiovascular Research) partner site Heidelberg/Mannheim, Heidelberg, Germany.
Mullens W; BIOMED - Biomedical Research Institute, Faculty of Medicine and Life Sciences, Hasselt University, Diepenbeek, Belgium.; Department of Cardiology, Ziekenhuis Oost-Limburg, Genk, Belgium.
Chioncel O; University of Medicine Carol Davila, Bucharest, Romania.; Emergency Institute for Cardiovascular Diseases, 'Prof. C. C. Iliescu', Bucharest, Romania.
de Boer RA; Department of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
Anker S; Division of Cardiology and Metabolism, Department of Cardiology (CVK), Charité, Berlin, Germany.; Berlin-Brandenburg Center for Regenerative Therapies (BCRT), Berlin, Germany.; DZHK (German Centre for Cardiovascular Research) partner site Berlin, Charité, Berlin, Germany.
Rapezzi C; Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy.
Coats AJS; Monash University, Australia, and University of Warwick, Coventry, UK.; Pharmacology, Centre of Clinical and Experimental Medicine, IRCCS San Raffaele Pisana, Rome, Italy, and St George's University of London, London, UK.
Tschöpe C; Berlin-Brandenburg Center for Regenerative Therapies, Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK) Berlin, Department of Cardiology, Campus Virchow Klinikum, Charite - Universitaetsmedizin Berlin, Berlin, Germany.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2019 May; Vol. 21 (5), pp. 553-576. Date of Electronic Publication: 2019 Apr 16.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiomyopathy, Dilated/*complications
Cardiomyopathy, Hypertrophic/*complications
Cardiomyopathy, Restrictive/*complications
Heart Failure/*etiology
Cardiomyopathies/complications ; Cardiomyopathies/physiopathology ; Cardiomyopathies/therapy ; Cardiomyopathy, Dilated/physiopathology ; Cardiomyopathy, Dilated/therapy ; Cardiomyopathy, Hypertrophic/physiopathology ; Cardiomyopathy, Hypertrophic/therapy ; Cardiomyopathy, Restrictive/physiopathology ; Cardiomyopathy, Restrictive/therapy ; Disease Management ; Disease Progression ; Female ; Heart Failure/epidemiology ; Heart Failure/physiopathology ; Heart Failure/therapy ; Heart Transplantation ; Humans ; Male ; Pregnancy ; Pregnancy Complications, Cardiovascular/physiopathology ; Pregnancy Complications, Cardiovascular/therapy ; Puerperal Disorders/physiopathology ; Puerperal Disorders/therapy ; Stroke Volume
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Failure of intravenous immunoglobulin to improve cardiac function in parvovirus B19-associated chronic dilated cardiomyopathy.
Autorzy:
Lyle MA; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
Cooper LT; Department of Cardiovascular Medicine, Mayo Clinic, Jacksonville, FL, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2021 Feb; Vol. 23 (2), pp. 310-311. Date of Electronic Publication: 2021 Feb 18.
Typ publikacji:
Editorial; Comment
MeSH Terms:
Cardiomyopathy, Dilated*
Heart Failure*
Parvoviridae Infections*
Parvovirus B19, Human*
Humans ; Immunoglobulins, Intravenous
Opinia redakcyjna
Pełny tekst  Link otwiera się w nowym oknieSzczegóły
Tytuł:
The electrocardiogram in the diagnosis and management of patients with dilated cardiomyopathy.
Autorzy:
Finocchiaro G; Cardiothoracic Centre, Guy's and St Thomas' Hospital, London, UK.
Merlo M; Cardiovascular Department, A.O.U. Ospedali Riuniti, Trieste, Italy.
Sheikh N; Cardiothoracic Centre, Guy's and St Thomas' Hospital, London, UK.
De Angelis G; Cardiovascular Department, A.O.U. Ospedali Riuniti, Trieste, Italy.
Papadakis M; Cardiology Clinical and Academic Group St George's, University of London, London and St George's University Hospital NHS Foundation Trust, London, UK.
Olivotto I; Cardiomyopathy Unit, Careggi University Hospital, Florence, Italy.
Rapezzi C; Cardiology, University of Ferrara and Maria Cecilia Hospital, Cotignola, Italy.; GVM Care & Research, Cotignola, Italy.
Carr-White G; Cardiothoracic Centre, Guy's and St Thomas' Hospital, London, UK.
Sharma S; Cardiology Clinical and Academic Group St George's, University of London, London and St George's University Hospital NHS Foundation Trust, London, UK.
Mestroni L; Cardiovascular Institute and Adult Medical Genetics Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Sinagra G; Cardiovascular Department, A.O.U. Ospedali Riuniti, Trieste, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Jul; Vol. 22 (7), pp. 1097-1107. Date of Electronic Publication: 2020 Apr 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Cardiomyopathy, Dilated*/diagnosis
Cardiomyopathy, Dilated*/genetics
Cardiomyopathy, Dilated*/therapy
Heart Failure*
Echocardiography ; Electrocardiography ; Humans ; Risk Assessment
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Predictors of left ventricular remodelling in patients with dilated cardiomyopathy - a cardiovascular magnetic resonance study.
Autorzy:
Tayal U; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Wage R; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Newsome S; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Manivarmane R; Department of Echocardiography, Royal Brompton Hospital, London, UK.
Izgi C; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Muthumala A; North Middlesex University Hospital and St Bartholomew's Hospital, London, UK.
Dungu JN; Essex Cardiothoracic Centre, Basildon, UK.
Assomull R; Imperial College NHS Trust, UK.
Hatipoglu S; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Halliday BP; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Lota AS; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Ware JS; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.; MRC London Institute of Medical Sciences, London, UK.
Gregson J; Department of Medical Statistics, London School of Hygiene and Tropical Medicine, London, UK.
Frenneaux M; National Heart Lung Institute, Imperial College London, UK.; University of East Anglia, Norwich, UK.
Cook SA; Duke-National University of Singapore, Singapore.
Pennell DJ; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Scott AD; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Cleland JGF; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Prasad SK; National Heart Lung Institute, Imperial College London, UK.; Cardiovascular Magnetic Resonance Unit, Royal Brompton Hospital, London, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Jul; Vol. 22 (7), pp. 1160-1170. Date of Electronic Publication: 2020 Feb 13.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Dilated*/diagnostic imaging
Heart Failure*
Ventricular Dysfunction, Left*
Contrast Media ; Female ; Gadolinium ; Humans ; Magnetic Resonance Spectroscopy ; Male ; Myocardial Contraction ; Prospective Studies ; Stroke Volume ; Ventricular Function, Left ; Ventricular Remodeling
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Contemporary survival trends and aetiological characterization in non-ischaemic dilated cardiomyopathy.
Autorzy:
Merlo M; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Cannatà A; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.; Department of Cardiovascular Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Pio Loco C; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Stolfo D; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Barbati G; Biostatistics Unit, University of Trieste, Trieste, Italy.
Artico J; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Gentile P; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
De Paris V; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Ramani F; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Zecchin M; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Gigli M; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Pinamonti B; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Korcova R; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Di Lenarda A; Cardiovascular Centre, Azienda Sanitaria Universitaria Integrata of Trieste (ASUITS), University of Trieste, Trieste, Italy.
Giacca M; Department of Cardiovascular Sciences, Faculty of Life Sciences & Medicine, King's College London, London, UK.
Mestroni L; Cardiovascular Institute and Adult Medical Genetics Program, University of Colorado Anschutz Medical Campus, Aurora, CO, USA.
Camici PG; Vita Salute University and San Raffaele Hospital, Milan, Italy.
Sinagra G; Cardiovascular Department, Centre for Diagnosis and Management of Cardiomyopathies, Azienda Sanitaria Universitaria Integrata di Trieste (ASUITS), University of Trieste, Trieste, Italy.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Jul; Vol. 22 (7), pp. 1111-1121. Date of Electronic Publication: 2020 Jun 26.
Typ publikacji:
Journal Article
MeSH Terms:
Cardiomyopathy, Dilated*/epidemiology
Heart Failure*
Adult ; Aged ; Heart Transplantation ; Humans ; Middle Aged ; Prognosis ; Risk Factors
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Biventricular pacemaker therapy improves exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy via augmented diastolic filling on exercise.
Autorzy:
Ahmed I; Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK.
Loudon BL; Norwich Medical School, University of East Anglia, Norwich, UK.
Abozguia K; Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK.; Lancashire Cardiac Centre, Blackpool Victoria Hospital, Blackpool, UK.
Cameron D; Norwich Medical School, University of East Anglia, Norwich, UK.
Shivu GN; Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK.
Phan TT; Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK.; Cardiology Department, Royal Stoke University Hospital UHNM NHS Trust, Newcastle, UK.
Maher A; Department of Cardiovascular Medicine, University of Birmingham, Birmingham, UK.
Stegemann B; Bakken Research Centre, Medtronic Inc., Maastricht, The Netherlands.
Chow A; Department of Cardiovascular Medicine, Royal Berkshire NHS Foundation Trust, Reading, UK.
Marshall H; Queen Elizabeth Hospital Birmingham, Welcome Trust Clinical Research Facility, Birmingham, UK.
Nightingale P; Queen Elizabeth Hospital Birmingham, Welcome Trust Clinical Research Facility, Birmingham, UK.
Leyva F; Department of Cardiovascular Medicine, Queen Elizabeth Hospital, Birmingham, UK.
Vassiliou VS; Norwich Medical School, University of East Anglia, Norwich, UK.
McKenna WJ; Institute of Cardiovascular Science, University College of London, London, UK.
Elliott P; Institute of Cardiovascular Science, University College of London, London, UK.
Frenneaux MP; Norwich Medical School, University of East Anglia, Norwich, UK.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Jul; Vol. 22 (7), pp. 1263-1272. Date of Electronic Publication: 2020 Jan 23.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cardiomyopathy, Hypertrophic*/therapy
Heart Failure*/therapy
Pacemaker, Artificial*
Cardiac Pacing, Artificial ; Cardiac Resynchronization Therapy Devices ; Cross-Over Studies ; Diastole ; Exercise Tolerance ; Female ; Humans ; Male ; Middle Aged ; Quality of Life ; Stroke Volume ; Ventricular Function, Left
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Tytuł:
Hypertrophic cardiomyopathy: the future of treatment.
Autorzy:
Tuohy CV; Oregon Health and Sciences University (OHSU), Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, OR, USA.
Kaul S; Oregon Health and Sciences University (OHSU), Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, OR, USA.
Song HK; Oregon Health and Sciences University (OHSU), Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, OR, USA.
Nazer B; Oregon Health and Sciences University (OHSU), Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, OR, USA.
Heitner SB; Oregon Health and Sciences University (OHSU), Division of Cardiovascular Medicine, Knight Cardiovascular Institute, Portland, OR, USA.
Pokaż więcej
Źródło:
European journal of heart failure [Eur J Heart Fail] 2020 Feb; Vol. 22 (2), pp. 228-240. Date of Electronic Publication: 2020 Jan 09.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't; Review
MeSH Terms:
Cardiomyopathy, Hypertrophic*/genetics
Cardiomyopathy, Hypertrophic*/therapy
Heart Failure*
Cardiac Surgical Procedures ; Humans ; Mitral Valve ; Treatment Outcome
Czasopismo naukowe
Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
Wyświetlanie 1-20 z 1654

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies